NO970440L - Celler som bærer CD4-lokkereseptorer og relaterte molekyler og fremgangsmåter - Google Patents

Celler som bærer CD4-lokkereseptorer og relaterte molekyler og fremgangsmåter

Info

Publication number
NO970440L
NO970440L NO970440A NO970440A NO970440L NO 970440 L NO970440 L NO 970440L NO 970440 A NO970440 A NO 970440A NO 970440 A NO970440 A NO 970440A NO 970440 L NO970440 L NO 970440L
Authority
NO
Norway
Prior art keywords
receptors
locomotor
processes
cells carrying
related molecules
Prior art date
Application number
NO970440A
Other languages
English (en)
Other versions
NO325081B1 (no
NO970440D0 (no
Inventor
Brian Seed
Babak Banapour
Charles Romeo
Waldemar Kolanus
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/284,391 external-priority patent/US5851828A/en
Priority claimed from US08/394,388 external-priority patent/US6753162B1/en
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of NO970440D0 publication Critical patent/NO970440D0/no
Publication of NO970440L publication Critical patent/NO970440L/no
Publication of NO325081B1 publication Critical patent/NO325081B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19970440A 1994-08-02 1997-01-31 Anvendelse av terapeutiske celler som inkluderer et fragment av CD4 for fremstilling av en farmasoytisk sammensetning for behandling av HIV. NO325081B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/284,391 US5851828A (en) 1991-03-07 1994-08-02 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US08/394,388 US6753162B1 (en) 1991-03-07 1995-02-24 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
PCT/US1995/009468 WO1996003883A1 (en) 1994-08-02 1995-07-26 Cells bearing cd4 decoy receptors and related molecules and methods

Publications (3)

Publication Number Publication Date
NO970440D0 NO970440D0 (no) 1997-01-31
NO970440L true NO970440L (no) 1997-03-26
NO325081B1 NO325081B1 (no) 2008-01-28

Family

ID=26962581

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970440A NO325081B1 (no) 1994-08-02 1997-01-31 Anvendelse av terapeutiske celler som inkluderer et fragment av CD4 for fremstilling av en farmasoytisk sammensetning for behandling av HIV.

Country Status (22)

Country Link
EP (1) EP0781095B1 (no)
JP (1) JP3832856B2 (no)
KR (1) KR100384249B1 (no)
CN (1) CN1142941C (no)
AT (1) ATE234011T1 (no)
AU (1) AU697489B2 (no)
CA (1) CA2195653C (no)
CZ (1) CZ293943B6 (no)
DE (1) DE69529910T2 (no)
DK (1) DK0781095T3 (no)
ES (1) ES2191058T3 (no)
FI (1) FI119868B (no)
HK (1) HK1002545A1 (no)
HU (1) HU221603B (no)
IL (1) IL114778A (no)
MX (1) MX9700800A (no)
NO (1) NO325081B1 (no)
NZ (1) NZ291017A (no)
PL (1) PL181085B1 (no)
PT (1) PT781095E (no)
UA (1) UA45349C2 (no)
WO (1) WO1996003883A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544523B1 (en) 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
PL349068A1 (en) * 1998-09-23 2002-07-01 Zymogenetics Inc Cytokine receptor zalpha11
US11440946B2 (en) * 2015-03-13 2022-09-13 University Of Maryland, Baltimore Universal antibody-mediated biosensor
JP6751493B2 (ja) 2015-08-05 2020-09-09 セルレブメド インコーポレーテッド キメラ抗原受容体及びキメラ抗原受容体が発現されたｔ細胞
JP6991131B2 (ja) * 2015-09-22 2022-02-03 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Ｈｉｖ感染症を処置するためにｔ細胞を再度方向付ける方法
CN114728174A (zh) * 2019-09-24 2022-07-08 加利福尼亚大学董事会 具有异源跨膜结构域的受体
EP4034255A4 (en) * 2019-09-24 2023-11-08 The Regents Of The University Of California NOTCH RECEPTORS WITH MINIMAL LEFT
US20220348628A1 (en) * 2019-09-24 2022-11-03 The Regents Of The University Of California Novel receptors having a fibronectin repeat for ligand-dependent transcriptional regulation
BR112022005283A2 (pt) * 2019-09-24 2022-08-16 Univ California Receptores notch com domínio de dobradiça
CN112176037A (zh) * 2020-09-24 2021-01-05 深圳普瑞金生物药业有限公司 检测car-t细胞目的基因拷贝数的方法、引物对、探针及试剂盒
EP4112639A1 (en) * 2021-07-02 2023-01-04 Universitat de Barcelona Car t/nk-cells for use in the treatment of invasive fungal infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6463394A (en) * 1987-09-04 1989-03-09 Kyowa Hakko Kogyo Kk Novel chimera polypeptide
PT89484B (pt) * 1988-01-22 1994-03-31 Gen Hospital Corp Genes clonados codificadores de proteinas de fusao ig-cd4 e sua utilizacao
IL101147A (en) * 1991-03-07 2004-06-20 Gen Hospital Corp Change of direction of cellular immunity by chimera receptors
US5851828A (en) * 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells

Also Published As

Publication number Publication date
JP3832856B2 (ja) 2006-10-11
HU221603B (hu) 2002-11-28
FI970428A (fi) 1997-03-26
DE69529910T2 (de) 2003-12-18
JPH10503932A (ja) 1998-04-14
CZ26497A3 (en) 1997-10-15
CA2195653A1 (en) 1996-02-15
DE69529910D1 (de) 2003-04-17
EP0781095B1 (en) 2003-03-12
IL114778A (en) 2008-08-07
PL181085B1 (pl) 2001-05-31
NZ291017A (en) 1998-05-27
FI119868B (fi) 2009-04-30
CN1158552A (zh) 1997-09-03
EP0781095A1 (en) 1997-07-02
IL114778A0 (en) 1995-11-27
CZ293943B6 (cs) 2004-08-18
EP0781095A4 (en) 1999-03-03
PT781095E (pt) 2003-06-30
KR100384249B1 (ko) 2003-08-30
HK1002545A1 (en) 1998-09-04
WO1996003883A1 (en) 1996-02-15
KR970704357A (ko) 1997-09-06
PL318443A1 (en) 1997-06-09
NO325081B1 (no) 2008-01-28
UA45349C2 (uk) 2002-04-15
ATE234011T1 (de) 2003-03-15
AU3201495A (en) 1996-03-04
CN1142941C (zh) 2004-03-24
FI970428A0 (fi) 1997-01-31
CA2195653C (en) 2010-04-27
ES2191058T3 (es) 2003-09-01
DK0781095T3 (da) 2003-06-23
AU697489B2 (en) 1998-10-08
NO970440D0 (no) 1997-01-31
HUT77253A (hu) 1998-03-02
MX9700800A (es) 1997-11-29

Similar Documents

Publication Publication Date Title
FI963150A0 (fi) HIV-infektoitujen solujen kohdistettu sytolyysi kimeeristä CD4-reseptoria sisältävillä soluille
NO970440L (no) Celler som bærer CD4-lokkereseptorer og relaterte molekyler og fremgangsmåter
DE69130741T2 (de) Immunogene peptide, antikörper sowie deren verwendungen im zusammenhang mit der cd4-rezeptorbindung
NO995044L (no) Osteoprotegerinbindende proteiner og reseptorer
DE69534235D1 (de) Cytokin lerk-7
EP1392835A4 (en) EPRESSION VECTOR FOR ANIMAL CELLS
ES2010727A6 (es) Metodo para producir lineas celulares que producen anticuerpos monoclonales reactivos frente a determinantes antigenicos de gp110 o de p25 de hiv.
AR003407A1 (es) Procedimiento de clonacion de un acido nucleico que codifica una proteina con actividad de delta-5,7-esterol, delta-7-reductasa, procedimiento de preparacion de la proteina, procemiento de reduccion in vitro de un esterol insaturado, procedimiento de produccion de pregnenolona, cepa de levadura transformada y metodo de diagnostico in vitro para la deteccion de la deficiencia de delta-5, 7-esterol, delta-7-reductasa
DK0629238T3 (da) Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi
DE59611293D1 (de) Protein mit dnase-aktivität
DE69227618D1 (de) Die verwendung des leukozyten adhäsionsmolekül-1- aus endothelzellen und antikörper dagegen in der behandlung von asthma
DE69631624D1 (de) Antikörper gegen menschliches restrictin
NZ330034A (en) Method of treating HIV in mammals by administering cells bearing CD4 decoy receptors
MY143222A (en) Expression vector for animal cell
NO922447L (no) Hybridmolekyler med translokasjonsregion og cellebindenderegion

Legal Events

Date Code Title Description
MK1K Patent expired